latest news
Next Generation
only medics is delighted to announce its acquisition by Caroline Lock and James Nyssen, directors of Clinical Professionals Ltd, one of Europe's leading pharmaceutical R&D staffing businesses. Clinical Professionals is dedicated to recruiting for Pharmaceutical, Biotechnology, Devices and CRO industries throughout Europe. Incorporated in 2005 only medics was the brainchild of Elaine Ford. Over the past 4 years only medics has worked with more than 90 client companies across the Pharmaceutical, CRO, Biotechnology and Regulatory sectors, establishing only medics as the recruitment provider of choice for pharmaceutical physicians.
From March 2009, the company will operate as Only Medics Recruitment Ltd. Full contact details are on the Contact Us page. It will continue to specialise exclusively in recruiting pharmaceutical physicians but take advantage of operational synergies with Clinical Professionals. Elaine Ford will be involved as a Non-Executive Director but the company will be run on a day-to-day level by Caroline Lock.
The mantra of only medics has always been one of treating candidates and clients with equal care, respect and integrity. It is important to us that these core values are maintained. We're confident that the high standards and specialism only medics clients and candidates have come to expect will continue. In particular, we intend to retain the personal touch for which only medics has become famous, continue providing a specialist solution for only medics existing clients and candidates and build on the success of only medics to maximise the service offering throughout Europe.
We look forward to working with you in the future, however, if you have any questions please do not hesitate to get in touch on 01189 522799 or email caroline@onlymedics.com
Who's Who of Britain's Business Elite 2009
Following the inclusion of Elaine and Rob Ford, in the 2008 edition of Who's Who of Britain's Most Succesful Business Owners, we were delighted to hear they have now been selected for inclusion in the 2009 Millennium Edition of Who's Who of Britain's Business Elite. Entry into the publication is by selection only and according to strictly determined criteria based on the performance and profiling of a company. Only Directors of the top performing 1% of companies trading in the UK since the year 2000 are eligible for inclusion into this title.
Pharmaceutical Companies to Weather Global Recession
AstraZeneca's chief executive David Brennan recently voiced that the pharmaceutical industry could be one of the top performing sectors during the global recession but must keep on adapting its business model. Addressing an industry audience at a Financial Times conference in London earlier this month, Brennan harked back to the recession of 1990-91, when pharma's stocks had provided a 'safe haven' for investors while other sectors were performing badly. He went on to say the sector as a whole was the best performing of all industries over the five consecutive quarters of recession experienced 18 years ago. He said talk of pharma being 'recession proof' was again in currency and agreed that healthcare was needed regardless of economy.
Financial analysts at Datamonitor recently commented that pharmaceutical companies are not only expected to weather global recession successfully but might also use this time “to exploit their unique cash strength by embarking on an acquisition spree”. Recent global issues have led to “the abrupt loss of cheap debt” and in the last decade, companies in other industries have exploited easy access to cheap debt to leverage their return to investors but the the sub-prime crisis in the US and the collapse of big name financial institutions means “banks have no choice but to protect their own capital and stop lending”. Pharmaceutical companies “have wisely stayed out of the cheap debt game and as a result, the credit crunch may play out as a net positive.”
PricewaterhouseCoopers' report from the Health Research Institute identifies 9 significant issues that will impact the health industry in 2009. The report discusses how innovators in the health industry may be able to profit and grow their business in 2009 despite adverse economic realities and predictions that the economy will continue to slow. It also addresses the implications of these issues for businesses and the pharmaceutical industry-at-large. You can read/download a copy of this report on the Downloads page of the Resources section. Simply scroll down to 'Current Pharmaceutical Industry Topics.'
The Textbook of Pharmaceutical Medicine
A question we're often asked by by those new to the industry or looking to change career is 'do you know of an up to date book about pharmaceutical medicine?' We usually recommend The Textbook of Pharmaceutical Medicine which is also the coursebook for the Diploma in Pharmaceutical Medicine. For those with £99.50 burning a hole in their pockets, it's available from Amazon or alternatively you can gain 24 hour online access to 1 or more of the 26 chapters at Wiley Interscience at $29.95 per chapter.
|
